Skip to main content
Clinical Trials/NCT02264457
NCT02264457UnknownPhase 4

A Randomised Intra-patient Comparison of Closed Loop and Plate Haptic Toric, Aspheric, Aberration Neutral, Hydrophilic Acrylic Intraocular Lenses in Patients With Bilateral Astigmatism

University of Plymouth2 sites in 1 country30 target enrollmentStarted: June 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Enrollment
30
Locations
2
Primary Endpoint
Best-corrected visual acuity

Study Overview

Brief Summary

During cataract surgery an artificial lens is implanted in the eye. These artificial lenses are called intraocular lenses (IOLs) and there are many different types of IOL designs. Your eyes have astigmatism, which is a normal and common characteristic of the eye. If left uncorrected the astigmatism would mean that you would need to wear spectacles for viewing distance objects. New IOL designs called toric IOLs help to correct the astigmatism to improve your vision after cataract surgery. This study has been designed to look at how well a toric IOL corrects this astigmatism so that you do not need to wear spectacles for viewing distance objects. There are many designs of these toric IOLs and for this study we are looking to compare two different designs of toric IOLs by putting one lens in your right eye and a different type of lens in your left eye. Both lenses are commercially available and are commonly implanted IOLs. Using new non-invasive methods we hope to be able to better judge the visual performance of these lenses and the ability of these lenses to correct astigmatism. In addition the study will involve imaging and examining the IOLs to determine the prevalence of any post-operative complications.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 50-75 years, bilateral significant corneal astigmatism >1.50D.
  • Requiring a Toric IOL within the following power range:
  • Sphere +6.00D to +30.00D
  • Cylinder +1.00D to +6.00D

Exclusion Criteria

  • Amblyopia,
  • predicted bilateral post-op corneal astigmatism of <1.50D,
  • irregular astigmatism,
  • dilated pupil size smaller than 5mm,
  • macular pathology,
  • glaucoma,
  • retinal disease,
  • corneal disease,
  • abnormal iris,
  • pupil deformation and
  • any previous corneal or intraocular surgery.

Arms & Interventions

First eye plate haptic

Other

subjects implanted with the plate haptic toric during first eye surgery and the closed loop haptic toric intraocular lens during second eye surgery

Intervention: T-flex Aspheric Toric IOL (Device)

First eye closed loop haptic

Other

subjects implanted with the Closed loop haptic during first eye surgery and the plate haptics toric intraocular lens during second eye surgery

Intervention: T-flex Aspheric Toric IOL (Device)

First eye closed loop haptic

Other

subjects implanted with the Closed loop haptic during first eye surgery and the plate haptics toric intraocular lens during second eye surgery

Intervention: AT TORBI toric IOL (Device)

First eye plate haptic

Other

subjects implanted with the plate haptic toric during first eye surgery and the closed loop haptic toric intraocular lens during second eye surgery

Intervention: AT TORBI toric IOL (Device)

Outcomes

Primary Outcomes

Best-corrected visual acuity

Time Frame: Visit 1 (1-2 days post implantation), visit 2 (1-2 weeks post implantation), visit 3 (1-2 months post implantation) and visit 4 (3-4 months

Secondary Outcomes

  • IOL centration(Visit 1 (1-2 days post implantation), visit 2 (1-2 weeks post implantation), visit 3 (1-2 months post implantation) and visit 4 (3-4 months))
  • Manifest refraction(Visit 1 (1-2 days post implantation), visit 2 (1-2 weeks post implantation), visit 3 (1-2 months post implantation) and visit 4 (3-4 months))
  • Rotational stability(Visit 1 (1-2 days post implantation), visit 2 (1-2 weeks post implantation), visit 3 (1-2 months post implantation) and visit 4 (3-4 months))
  • Prevalence of posterior capsular Opacification(visit 4 (3-4 months))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr Phillip J Buckhurst

Associate Professor (Senior Lecturer)

University of Plymouth

Study Sites (2)

Loading locations...

Similar Trials

A Intra-patient Comparison of Closed Loop... | Clinical Trial